Thursday, October 06, 2022 11:48:44 PM
Completely in agreement with your statements.
They will PR MAA acceptance. They will be shouting from the rooftop, just watch! They actually appear desperate, shows from their PIP approval PR. Also a strong indication that MAA acceptance is far off. If it was going to be close there was no reason to PR PIP news. No one does that! The reality is they have been playing with retail all this while with their carefully crafted (ambiguous) PRs.
By the way, LG, DI, and LP are BS artists. Remember how DI and LG told posters that publication was submitted when posters reported their calls from Jan-Feb! Ashkan’s statements today confirmed that it wasn’t submitted until after NYAS presentation at the earliest.
LP said at a virtual science conference in summer 2020 that they can’t wait to reveal the unblinded data to the community in the coming weeks.
They will PR MAA acceptance. They will be shouting from the rooftop, just watch! They actually appear desperate, shows from their PIP approval PR. Also a strong indication that MAA acceptance is far off. If it was going to be close there was no reason to PR PIP news. No one does that! The reality is they have been playing with retail all this while with their carefully crafted (ambiguous) PRs.
By the way, LG, DI, and LP are BS artists. Remember how DI and LG told posters that publication was submitted when posters reported their calls from Jan-Feb! Ashkan’s statements today confirmed that it wasn’t submitted until after NYAS presentation at the earliest.
LP said at a virtual science conference in summer 2020 that they can’t wait to reveal the unblinded data to the community in the coming weeks.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
